Knock-down of the 37kDa/67kDa laminin receptor LRP/LR impedes telomerase activity.
Da Costa Dias, B.
Public Library of Science.
Cancer has become a major problem worldwide due to its increasing incidence and mortality rates. Both the 37kDa/67kDa laminin receptor (LRP/LR) and telomerase are overexpressed in cancer cells. LRP/LR enhances the invasiveness of cancer cells thereby promoting metastasis, supporting angiogenesis and hampering apoptosis. An essential component of telomerase, hTERT is overexpressed in 85-90% of most cancers. hTERT expression and increased telomerase activity are associated with tumor progression. As LRP/LR and hTERT both play a role in cancer progression, we investigated a possible correlation between LRP/LR and telomerase. LRP/LR and hTERT co-localized in the perinuclear compartment of tumorigenic breast cancer (MDA-MB231) cells and non-tumorigenic human embryonic kidney (HEK293) cells. FLAG® Co-immunoprecipitation assays confirmed an interaction between LRP/LR and hTERT. In addition, flow cytometry revealed that both cell lines displayed high cell surface and intracellular LRP/LR and hTERT levels. Knock-down of LRP/LR by RNAi technology significantly reduced telomerase activity. These results suggest for the first time a novel function of LRP/LR in contributing to telomerase activity. siRNAs targeting LRP/LR may act as a potential alternative therapeutic tool for cancer treatment by (i) blocking metastasis (ii) promoting angiogenesis (iii) inducing apoptosis and (iv) impeding telomerase activity.
laminin receptor; , small interfering RNA; , telomerase; , breast cancer; , cancer cell line; , cell level; , cell nucleus; , cell surface; , controlled study; , embryo; , enzyme activity; , gene silencing; , HEK293 cell line; , human; human cell; , MB231 cell line; , protein function; , protein localization; , protein protein interaction; , RNA interference;
Naidoo, K. et al. 2015. Knock-down of the 37kDa/67kDa laminin receptor LRP/LR impedes telomerase activity. PLoS ONE 10(11): e0141618.